Skip to content

COMMENT: Tackle motion sickness, or forget about AVs

Riders in autonomous vehicles may never benefit from the promise of increased productivity unless motion sickness can be addressed, writes Freddie Holmes

Travel sickness is an age-old problem that inconveniences passengers to varying degrees across any form of transport. However, based on the marketing behind autonomous vehicles (AVs) thus far, the issue seems to sit fairly low on the list of priorities. For all the effort being directed toward the development of shared robo-taxis, if these vehicles lead to motion sickness that make riders feel unwell, it's a safe bet that they will find an alternative form of transport that does not.

It’s time to log in (or subscribe).

Not a member? Subscribe now and let us help you understand the future of mobility.

Pro
£495/year
or £49.50/month
1 user
News
yes
Magazine
yes
Articles
yes
Special Reports
yes
Research
no
OEM Tracker
no
OEM Model Plans
no
OEM Production Data
no
OEM Sales Data
no
Pro+
£1,950/year
or £195/month
1 user
News
yes
Magazine
yes
Articles
yes
Special Reports
yes
Research
yes
OEM Tracker
yes
OEM Model Plans
yes
OEM Production Data
yes
OEM Sales Data
yes
Pro+ Team
£3,950/year
or £395/month
Up to 5 users
News
yes
Magazine
yes
Articles
yes
Special Reports
yes
Research
yes
OEM Tracker
yes
OEM Model Plans
yes
OEM Production Data
yes
OEM Sales Data
yes
Pro+ Enterprise
Unlimited
News
yes
Magazine
yes
Articles
yes
Special Reports
yes
Research
yes
OEM Tracker
yes
OEM Model Plans
yes
OEM Production Data
yes
OEM Sales Data
yes

Welcome back , to continue browsing the site, please click here